In vitro activity of two phenyl-carbamate derivatives, singly and in combination with albendazole against albendazole-resistant Giardia intestinalis

Angeles, 2000, Ethyl and methyl-phenylcarbamates as antihelmintic agents; theoretical study for predicting their biological activity by PM3, J. Mol. Struct. (Teochem)., 504, 141, 10.1016/S0166-1280(00)00361-4 Angeles, 1994, A simple method for the synthesis of carbamates, Synth. Commun., 24, 2441, 10.1080/00397919408010552 European Committee for Antimicrobial Susceptibility Testing (EUCAST), 2000. Terminology relating to methods for the determination of susceptibility of bacterial to antimicrobial agents. Clin. Microbiol. Infect. 6, 503–508. el Sayad, 2002, Efficacy of praziquantel against Giardia lamblia in rats: parasitological, pathological and therapeutic study, J. Egypt. Soc. Parasitol., 32, 201 Farthing, 1997, The molecular pathogenesis of giardiasis, J. Pediatr. Gastroenterol. Nutr., 24, 79, 10.1097/00005176-199701000-00018 Gardner, 2001, Treatment of giardiasis, Clin. Microbiol. Rev., 14, 114, 10.1128/CMR.14.1.114-128.2001 Jiménez-Cardoso, 2003, In vitro antigiardial activity of IRE-6A and IRE-7B, two ethyl-phenylcarbamate derivatives, Rev. Invest. Clin., 55, 444 Guerrant, 1990, Diarrhea in developed and developing countries: magnitude, special settings, and etiologies, Rev. Infect. Dis., 12, 41, 10.1093/clinids/12.Supplement_1.S41 Hollomon, D.W., Butters, J.A., Baker, H., 1997. Tubulins: a target for antifungal agents. In: Bentley, P.H., O’Hanlon, P.J. (Eds.), Anti-infectives: Recent Advances in Chemistry and Structure Activity Relationship, Royal Society of Chemistry, London, UK, pp. 152–156. Hollomon, 1998, Fungal beta-tubulin expressed as a fusion protein, binds benzimidazole and phenylcarbamate fungicides, Antimicrob. Agents Chemother., 42, 2171, 10.1128/AAC.42.9.2171 Katelaris, 1994, Activity of metronidazole azithromycin and three benzimidazoles on Giardia lamblia growth and attachment to a human intestinal cell line, Aliment Pharmacol. Ther., 8, 187, 10.1111/j.1365-2036.1994.tb00277.x Kato, 1984, Negatively correlated cross-resistance between benzimidazole fungicides and methyl-(3,5-dichloraphenyl) carbamate, Noyaku Gakkaishi (J. Pestic. Sci.), 9, 489 Keister, 1983, Axenic culture of Giardia lamblia in TYI-S-33 medium supplemented with bile, Trans. R. Soc. Trop. Med. Hyg., 77, 487, 10.1016/0035-9203(83)90120-7 Kohler, 2001, The biochemical basis of antihelmintic action and resistance, Int. J. Parasitol., 31, 336, 10.1016/S0020-7519(01)00131-X Lemee, 2000, Metronidazole and albendazole susceptibility of 11 clinical isolates of Giardia duodenalis from France, J. Antimicrob. Chemother., 46, 819, 10.1093/jac/46.5.819 Lindquist, 1996, Induction of albendazole resistance in Giardia lamblia., Microb. Drug Resist., 2, 433, 10.1089/mdr.1996.2.433 Marti, 1996, A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children, Am. J. Trop. Med. Hyg., 55, 477, 10.4269/ajtmh.1996.55.477 Morgan, 1993, Activities of several benzimidazoles and tubulin inhibitors against Giardia ssp. in vitro, Antimicrob. Agents Chemother., 37, 328, 10.1128/AAC.37.2.328 Moya-Camarena, 2002, Effects of asymptomatic Giardia intestinalis infection on carbohydrate absorption in well-nourished Mexican children, Am. J. Trop. Med. Hyg., 66, 255, 10.4269/ajtmh.2002.66.255 Nash, 2001, Treatment of patients with refractory giardiasis, Clin. Infect. Dis., 33, 22, 10.1086/320886 Ortega, 1997, Giardia overview and update, Clin. Infect. Dis., 25, 545, 10.1086/513745 Rizztelli, 1997, Albendazole a new therapeutic regimen in cutaneous larva migrans, Int. J. Dermatol., 36, 700, 10.1046/j.1365-4362.1997.00263.x Rosenblatt, 1999, Antiparasitic agents, Mayo Clin. Proc., 74, 1161, 10.4065/74.11.1161 Tallarida, 2001, Drug synergism: its detection and applications, J. Pharmacol. Exp. Ther., 298, 865 Upcroft, 1996, Quinacrine-resistant Giardia duodenalis, Parasitology, 112, 309, 10.1017/S0031182000065823 Upcroft, 2001, Drug susceptibility testing of anaerobic protozoa, Antimicrob. Agents Chemother., 45, 1810, 10.1128/AAC.45.6.1810-1814.2001 Upcroft, 2001, Drug targets and mechanisms of resistance in the anaerobic protozoa, Clin. Microbiol. Rev., 14, 150, 10.1128/CMR.14.1.150-164.2001 Upcroft, 1996, Albendazole resistance in Giardia is correlated with cytoskeletal changes but not with a mutation at amino acid 200 in beta-tubulin, Microb. Drug Resist., 2, 303, 10.1089/mdr.1996.2.303 Vanelle, 1991, Studies on antiparasitic agents: effect of the lactam nucleus substitution in the 2-position on the in-vitro activity of new 5-nitroimidazoles, J. Pharm. Pharmacol., 43, 735, 10.1111/j.2042-7158.1991.tb03470.x Cacopardo, 1995, Synergic effect of albendazole plus metronidazole association in the treatment of metronidazole-resistant giardiasis, Clin. Ter., 146, 761